Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2006

01-11-2006 | Oral Presentation

Microarray studies reveal novel genes associated with endocrine resistance in breast cancer

Authors: RS Burmi, RA McClelland, D Barrow, IO Ellis, JFR Robertson, RI Nicholson, JMW Gee

Published in: Breast Cancer Research | Special Issue 2/2006

Login to get access

Excerpt

Endocrine resistance is a major hurdle in breast cancer management, and determining the underlying factors driving its growth and aggressive behaviour should vastly improve treatment. …
Metadata
Title
Microarray studies reveal novel genes associated with endocrine resistance in breast cancer
Authors
RS Burmi
RA McClelland
D Barrow
IO Ellis
JFR Robertson
RI Nicholson
JMW Gee
Publication date
01-11-2006
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2006
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1554

Other articles of this Special Issue 2/2006

Breast Cancer Research 2/2006 Go to the issue

Poster Presentation

Poly(ADPribosyl)ation of CTCF: role in breast tumourigenesis

Poster Presentation

Characterisation of the tumour suppressor gene ZACin breast tissue

Poster Presentation

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer

Poster Presentation

Increased regulatory T-cell numbers distinguish high-risk breast cancer patients and those at risk of late relapse

Oral Presentation

Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2

Oral Presentation

Translating breast cancer research into clinical practice — new approaches and better outcomes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits